Bank of New York Mellon’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,927
| Closed | -$245K | – | 4733 |
|
|
2022
Q1 | $245K | Buy |
4,927
+34
| +0.7% | +$1.69K | ﹤0.01% | 4132 |
|
|
2021
Q4 | $369K | Buy |
4,893
+105
| +2% | +$7.92K | ﹤0.01% | 3974 |
|
|
2021
Q3 | $378K | Buy |
4,788
+149
| +3% | +$11.8K | ﹤0.01% | 3948 |
|
|
2021
Q2 | $644K | Buy |
4,639
+576
| +14% | +$80K | ﹤0.01% | 3646 |
|
|
2021
Q1 | $850K | Buy |
4,063
+594
| +17% | +$124K | ﹤0.01% | 3421 |
|
|
2020
Q4 | $575K | Buy |
3,469
+371
| +12% | +$61.5K | ﹤0.01% | 3549 |
|
|
2020
Q3 | $527K | Sell |
3,098
-17
| -0.5% | -$2.89K | ﹤0.01% | 3462 |
|
|
2020
Q2 | $517K | Buy |
3,115
+791
| +34% | +$131K | ﹤0.01% | 3450 |
|
|
2020
Q1 | $270K | Buy |
2,324
+10
| +0.4% | +$1.16K | ﹤0.01% | 3642 |
|
|
2019
Q4 | $343K | Buy |
2,314
+438
| +23% | +$64.9K | ﹤0.01% | 3745 |
|
|
2019
Q3 | $257K | Buy |
+1,876
| New | +$257K | ﹤0.01% | 3825 |
|